← Eichor
Study identifier: NCT04071925 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

9000 URETHRA STUDY: a Study About Urethroplasty for Urethral Stricture Disease

Condition: Urethral Stricture  ·  Sponsor: University Hospital, Ghent

PhaseN/A
Planned participants1000
Who can joinAll sexes, 6 Years to 100 Years
Healthy volunteersNo

About this study

It has been demonstrated that urethroplasty should be considered the gold standard treatment for urethral stricture disease as it yields higher long-term success rates than endoscopic treatment options such as direct vision internal urethrotomy (DVIU) or dilation. Many data about these procedures exist, although most of the publications about urethroplasty are retrospective and involve a tremendous risk of bias. To address these issues, this study is designed to prospectively gain evidence about this matter in all patient subgroups facing a potential treatment with urethroplasty: native men, native women, transmen, transwomen and children.

This description comes directly from the study's public registry record.

Talk to the study team

Nicolaas Lumen  ·  +32 9 332 22 76  ·  nicolaas.lumen@uzgent.be

Wesley Verla  ·  +32 9 332 22 76  ·  wesley.verla@uzgent.be

Always discuss trial participation with your own doctor first.

Locations (2)

Dept. of Urology, Ghent University HospitalGhent, BelgiumNot Yet Recruiting
University Hospital GhentGhent, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04071925